The diagnosis and treatment of iron deficiency and its potential relationship to hair loss

Journal of the American Academy of Dermatology

Volumn 54, Issue 5, 2006, Pages 824-844

  Trost, Leonid Benjamin ^a   Bergfeld, Wilma Fowler ^a   Calogeras, Ellen ^b  

^a Unit of Dermatology   (Spain)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEMOGLOBIN; IRON; PROTOPORPHYRIN ZINC; TRANSFERRIN;

ALOPECIA AREATA; BLEEDING; DIETARY INTAKE; FERRITIN BLOOD LEVEL; GASTROINTESTINAL HEMORRHAGE; HAIR LOSS; HEMATOCRIT; HEMOCHROMATOSIS; HEMOGLOBIN DETERMINATION; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON OVERLOAD; IRON STORAGE; IRON THERAPY; MACROCYTIC ANEMIA; MALE TYPE ALOPECIA; MICROCYTIC ANEMIA; PRIORITY JOURNAL; REVIEW; SCREENING; SEX DIFFERENCE; TRANSFERRIN BLOOD LEVEL;

ALOPECIA; ANEMIA, IRON-DEFICIENCY; DIET; FEMALE; HUMANS; IRON; IRON OVERLOAD; MALE; RISK FACTORS;

EID: 33646090862     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2005.11.1104     Document Type: Review

References (49)

1. West C.E. Strategies to control nutritional anemia. Am J Clin Nutr 64 (1996) 789-790
2. Centers for Disease Control (CDC). Recommendations to prevent and control iron deficiency in the United States. Morb Mortal Wkly Rep 47 (1998) 1-36
3. Brittenham G.M. Disorders of iron metabolism: iron deficiency and overload. In: Hoffman R. (Ed). Hematology: basic principles and practice. 3rd ed. (2000), Churchill-Livingstone, New York 397-428
4. Centers for Disease Control (CDC). Iron deficiency-United States, 1999-2000. Morb Mortal Wkly Rep 51 (2002) 897-899
5. Looker A.C., Dallman P.R., Carroll M.D., Gunter E.W., and Johnson C.L. Prevalence of iron deficiency in the United States. JAMA 277 (1997) 973-976
6. Goddard A.F., McIntyre A.S., and Scott B.B. Guidelines for the management of iron deficiency anaemia. British Society of Gastroenterology Gut 46 (2000) IV1-IV5
7. Food and nutrient intakes by individuals in the United States, by sex and age. 2003: US Department of Agriculture, Agricultural Research Services; 1998.
8. Punnonen K., Irjala K., and Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 89 (1997) 1052-1057
9. Adamson J.W., and Longo D.L. Anemia and polycythemia. In: Kasper D.L., Braunwald E., Fauci A.S., Hauser S.L., Longo D.L., and Jameson J.L. (Eds). Harrison's principles of internal medicine. 16th ed. (2005), McGraw-Hill, New York 329-336
10. Arosio P., and Levi S. Ferritin, iron homeostatis, and oxidative damage. Free Radic Biol Med 33 (2002) 457-463
11. Schrier SL. Causes and diagnosis of anemia due to iron deficiency. Available from: www.UpToDate.com. Accessed April 18, 2005; last updated November 6, 2003.
12. Guyatt G.H., Oxman A.D., Ali M., Willan A., McIlroy W., and Patterson C. Laboratory diagnosis of iron-deficiency anemia: an overview. J Gen Intern Med 7 (1992) 145-153
13. Schrier SL, Bacon BR. Pathophysiology and diagnosis of iron overload symptoms. 2004. Available from: www.UpToDate.com. Accessed April 23, 2004; last updated January 9, 2004.
14. Weiss G., and Goodnough L.T. Anemia of chronic disease. N Engl J Med 352 (2005) 1011-1023
15. Herbert V. Everyone should be tested for iron disorders. J Am Diet Assoc 92 (1992) 1502-1509
16. Adamson J.W. Iron deficiency and other hypoproliferative anemias. In: Kasper D.L., Braunwald E., Fauci A.S., Hauser S.L., Longo D.L., and Jameson J.L. (Eds). Harrison's principles of internal medicine. 16th ed. (2005), McGraw-Hill, New York 586-592
17. Umbreit J. Iron deficiency: a concise review. Am J Hematol 78 (2005) 225-231
18. Harrison S., and Sinclair R. Telogen effluvium. Clin Dermatol 27 (2002) 389-395
19. Schrier SL. Approach to the patient with anemia. Available from: www.UpToDate.com. Accessed April 18, 2005; last updated November 22, 2004.
20. Tefferi A. Anemia in adults: a contemporary approach to diagnosis. Mayo Clinic Proc 78 (2003) 1274-1280
21. Sears D. Anemia of chronic disease. Med Clin North Am 76 (1992) 567-579
22. Young N.S. Aplastic anemia, myelodysplasia, and related bone marrow failure syndromes. In: Kasper D.L., Braunwald E., Fauci A.S., Hauser S.L., Longo D.L., and Jameson J.L. (Eds). Harrison's principles of internal medicine. 16th ed. (2005), McGraw-Hill, New York 617-626
23. Kantor J., Kessler L.J., Brooks D.G., and Cotsarelis G. Decreased serum ferritin is associated with alopecia in women. J Invest Dermatol 121 (2003) 985-988
24. Boffa M.J., Wood P., and Griffiths C.E. Iron status of patients with alopecia areata. Br J Dermatol 132 (1995) 662-664
25. White M., Currie J., and Williams M. A study of the tissue iron status of patients with alopecia areata. Br J Dermatol 130 (1994) 261-263
26. Sinclair R. There is no clear association between low serum ferritin and chronic diffuse telogen hair loss. Br J Dermatol 147 (2002) 982-984
27. Aydingoz I., Ferhanoglu B., and Guney O. Does tissue iron status have a role in female alopecia?. J Eur Acad Dermatol Venereol 13 (1999) 65-67
28. Rushton D.H., and Ramsey I.D. The importance of adequate serum ferritin levels during oral cyproterone acetate and ethinyl oestradiol treatment of diffuse androgen dependent alopecia in women. Clin Endocrinol 36 (1992) 421-427
29. Rushton D.H., Ramsay I.D., James K.C., Norris M.J., and Gilkes J.J. Biochemical and trichological characterization of diffuse alopecia in women. Br J Dermatol 123 (1990) 187-197
30. Rushton D.H. Nutritional factors and hair loss. Clin Exp Dermatol 27 (2002) 396-404
31. Rushton D.H., Norris M.J., Dover R., and Busuttil N. Causes of hair loss and the developments in hair rejuvenation. Int J Cosmet Sci 24 (2002) 17-23
32. Hard S. Non-anaemic iron deficiency as an etiologic factor in diffuse loss of hair of the scalp in women. Acta Derm Venereol 43 (1963) 562-569
33. Fiedler V.C., and Gray A.C. Diffuse alopecia: telogen hair loss. In: Olsen E.A. (Ed). Disorders of hair growth: diagnosis and treatment. 2nd ed. (2003), McGraw-Hill, New York 303-320
34. Institute of Medicine. Dietary reference intakes (DRIs) for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc (2002), National Academy Press, Washington (DC) pp. 18-9, 351
35. US Department of Agriculture and US Department of Health and Human Services. Nutrition and your health: dietary guidelines for Americans. (Home and Garden Bulletin No. 232) (1995), US Department of Agriculture and US Department of Health and Human Services, Washington (DC)
36. Ross E.M. Evaluation and treatment of iron deficiency in adults. Nutr Clin Care 5 (2002) 220-224
37. Venti C.A., and Johnston C.S. Modified food guide pyramid for lactovegetarians and vegans. J Nutr 132 (2002) 1050-1054
38. Schrier SL. Regulation of iron balance. Available from: www.UpToDate.com. Accessed April 18, 2005; last updated January 21, 2005.
39. World Health Organization. Iron deficiency anaemia: assessment, prevention, and control (2001), WHO, Geneva, Switzerland
40. Schrier SL. Treatment of anemia due to iron deficiency. Available from: www.UpToDate.com. Accessed April 18, 2005; last updated February 27, 2001.
41. McEvoy GK. AHFS drug information. Iron preparations, oral. Available from: http://online.statref.com/document.aspx?fxid=1&docid=365. Accessed June 4, 2005; last updated May 27, 2005.
42. McDiarmid T., and Johnson E.D. Are any oral iron formulations better tolerated than ferrous sulfate?. J Fam Pract 51 (2002) 576
43. Besarb A., Frinak S., and Yee J. An indistinct balance: the safety and efficacy of parenteral iron therapy. J Am Soc Nephrol 10 (1999) 2029-2043
44. Heath A.L.M., and Fairweather-Tait S.J. Health implications of iron overload: the role of diet and genotype. Nutr Rev 61 (2003) 45-62
45. Lynch S.R. Iron overload: prevalence and impact on health. Nutr Rev 53 (1995) 255-260
46. Bottomley S.S. Secondary iron overload disorders. Semin Hematol 35 (1998) 77-86
47. Norat T., Lukanova A., Ferrari P., and Riboli E. Meat consumption and colorectal cancer risk: dose-response meta-analysis of epidemiological studies. Int J Cancer 98 (2002) 241-256
48. Schrier SL, Bacon BR. Treatment of and screening for hereditary hemochromatosis. Available from: www.UpToDate.com. Accessed April 23, 2004; last updated January 9, 2004.
49. Mainous A.G., Gill J.M., and Pearson W.S. Should we screen for hemochromatosis? An examination of evidence of downstream effects on morbidity and mortality. Arch Intern Med 162 (2002) 1769-1774